Gnpx investor relations
Web1 day ago · GNPX Complete Genprex Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebMar 13, 2024 · AUSTIN, Texas, March 13, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, ... (877) 774-GNPX (4679) GNPX Investor Relations [email protected]. GNPX Media Contact Kalyn …
Gnpx investor relations
Did you know?
WebApr 13, 2024 · AUSTIN, Texas , March 23, 2024 /PRNewswire/ -- Rodney Varner , CEO of Genprex, Inc. ("Genprex" or the "Company") (Nasdaq: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today commended The U.S. Food and Drug Administration's (FDA) initiative …
WebAug 15, 2024 · (877) 774-GNPX (4679) GNPX Investor Relations [email protected] GNPX Media Contact Kalyn Dabbs [email protected] SOURCE Genprex, Inc. WebGenprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product …
WebJan 4, 2024 · (877) 774-GNPX (4679) GNPX Investor Relations [email protected]. GNPX Media Contact Kalyn Dabbs [email protected]. Cision. WebFeb 27, 2024 · Genprex, Inc. Announces $4 Million Registered Direct Offering With a Single, Healthcare-Focused Institutional Investor PR Newswire AUSTIN, Texas, Feb. 27, 2024 AUSTIN, Texas, Feb. 27, 2024 /PRNewsw...
WebDec 22, 2024 · Genprex, Inc. (877) 774-GNPX (4679) Investor Relations GNPX Investor Relations (877) 774-GNPX (4679) ext. #2 [email protected] Media Contact …
WebFeb 9, 2024 · Investor Relations GNPX Investor Relations (877) 774-GNPX (4679) ext. #2 [email protected] Media Contact Genprex Media Relations Kalyn Dabbs (877) 774-GNPX (4679) ext. #3 [email protected] ... cruises leaving sydney in april 2023WebFeb 9, 2024 · AUSTIN, Texas — (Feb. 9, 2024) — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its President and Chief Executive Officer, Rodney Varner, will provide an overview of … cruises leaving sydney february 2023WebOct 7, 2024 · (877) 774-GNPX (4679) GNPX Investor Relations [email protected]. GNPX Media Contact Kalyn Dabbs [email protected]. Cision. buildwide supplies incWebFind the latest Genprex, Inc. (GNPX) stock quote, history, news and other vital information to help you with your stock trading and investing. cruises leaving sydney 2020WebWe’re passionate about the work we’re doing to fight cancer and diabetes, and we want to keep our current and potential investors informed on our day-to-day advancements. For … GNPX Investor Relations. (877) 774-GNPX (4679) ext. #2. … build widthWebFeb 10, 2024 · See the latest Genprex Inc stock price (NASDAQ:GNPX), related news, valuation, dividends and more to help you make your investing decisions. ... Investor Relations ... Dividend yield allows ... cruises leaving sydney todayWebMar 24, 2024 · Event: Oncology Investor Conference (Virtual) Date: The conference will take place virtually March 29 - April 2, 2024 Presentation Date: Monday, March 29 Presentation Time: 2 p.m. Eastern Daylight ... cruises leaving sydney march 2023